[Weixinkang: Subsidiary obtains drug registration certificate for water-soluble vitamins for injection] On September 10, Weixinkang (603676.SH) announced that the company's wholly-owned subsidiary Baiyi Pharmaceutical has received the "Drug Registration Certificate" for water-soluble vitamins for injection approved and issued by the State Food and Drug Administration. The drug registration is classified as Class 3 chemical drugs and is deemed to have passed the consistency evaluation. As of the date of the announcement, a total of 33 domestic companies have been approved for this product, including 4 companies that have passed or are deemed to have passed the consistency evaluation. In 2025, the terminal sales volume of this drug in China's urban public hospitals and county-level public hospitals will be 112 million yuan.